SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001159036-22-000051
Filing Date
2022-08-09
Accepted
2022-08-09 16:13:39
Documents
14
Period of Report
2022-05-24
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A halo-20220524.htm   iXBRL 8-K/A 48630
2 EX-23.1 exhibit231-consentofindepe.htm EX-23.1 2659
3 EX-99.4 exhibit994-unauditedprofor.htm EX-99.4 480726
  Complete submission text file 0001159036-22-000051.txt   707209

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20220524.xsd EX-101.SCH 1915
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20220524_lab.xml EX-101.LAB 24137
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20220524_pre.xml EX-101.PRE 12520
8 EXTRACTED XBRL INSTANCE DOCUMENT halo-20220524_htm.xml XML 10828
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-32335 | Film No.: 221148463
SIC: 2836 Biological Products, (No Diagnostic Substances)